Pituitary gigantism: a rare learning opportunity

Area of Science:

• Pediatric Endocrinology
• Neuroendocrinology
• Surgical Oncology

Background:

• Pituitary gigantism is a rare pediatric condition requiring complex diagnosis and management.
• Transsphenoidal surgery (TSS) is the primary treatment, with medical therapy often used adjunctively.

Observation:

• A 10½-year-old boy presented with significant tall stature (+5.8 SD) and elevated insulin-like growth factor-1 (IGF-1).
• Initial MRI was inconclusive, but C-11 methionine PET-CT identified a 6mm pituitary microadenoma.
• Medical therapy with a somatostatin analogue was initiated due to patient factors, showing initial but ultimately insufficient response.

Findings:

• Despite initial positive response to octreotide, the patient's IGF-1 levels increased, and growth hormone (GH) was not fully suppressed.
• The patient subsequently underwent successful transsphenoidal surgery (TSS) for adenoma excision.

Implications:

• Individualized, multidisciplinary approaches are crucial for managing rare pediatric pituitary conditions.
• Sharing expertise across sites and disciplines is essential for optimal patient care.
• This case underscores the importance of timely surgical intervention when medical therapy for pituitary gigantism proves insufficient.